BACE1 and Alzheimer disease: Estrogen deficiencies have been associated with increased Aβ deposition via increased BACE1 activity and decreased neprilysin/insulin-degrading enzyme activity, both of which were detected as gender specific biochemical markers associated with aggressive plaque deposition in mouse models of AD [12], [13], [42].